The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

31 articles for R Bai


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery and preclinical evaluation of 7-benzyl-N-(substituted)-pyrrolo[3,2-d]pyrimidin-4-amines as single agents with microtubule targeting effects along with triple-acting angiokinase inhibition as antitumor agents.EBI
Duquesne University
Synthesis and evaluation of 2,5 and 2,6 pyridine-based CXCR4 inhibitors.EBI
Georgia State University
Novel Microtubule-Targeting 7-Deazahypoxanthines Derived from Marine Alkaloid Rigidins with Potent in Vitro and in Vivo Anticancer Activities.EBI
Texas State University
Novel 9'-substituted-noscapines: synthesis with Suzuki cross-coupling, structure elucidation and biological evaluation.EBI
University of Padova
Discovery of biarylaminoquinazolines as novel tubulin polymerization inhibitors.EBI
University of Padova
Discovery of antitubulin agents with antiangiogenic activity as single entities with multitarget chemotherapy potential.EBI
Duquesne University
Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists.EBI
China Pharmaceutical University
Actin is the primary cellular receptor of bistramide A.EBI
University of Chicago
Discovery of anti-inflammatory natural flavonoids: Diverse scaffolds and promising leads for drug discovery.EBI
Hangzhou Normal University
Synthetically Feasible De Novo Molecular Design of Leads Based on a Reinforcement Learning Model: AI-Assisted Discovery of an Anti-IBD Lead Targeting CXCR4.EBI
Hangzhou Normal University
Small-molecule agents for treating skin diseases.EBI
Hangzhou Normal University
Discovery of matrix metalloproteinase inhibitors as anti-skin photoaging agents.EBI
Hangzhou Normal University
Artificial Intelligence-Assisted Optimization of Antipigmentation Tyrosinase Inhibitors: De Novo Molecular Generation Based on a Low Activity Lead Compound.EBI
Hangzhou Normal University
Click chemistry-aided drug discovery: A retrospective and prospective outlook.EBI
Hangzhou Normal University
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1EBI
Catholic University of The Sacred Heart
Structure Guided Design, Synthesis, and Biological Evaluation of Oxetane-Containing Indole Analogues.EBI
Baylor University
Discovery of natural anti-inflammatory alkaloids: Potential leads for the drug discovery for the treatment of inflammation.EBI
Zhejiang University
Synthesis of Novel Kidney-Type Glutaminase Allosteric Inhibitors Targeting the Critical Lys-320 Residue.EBI
Zhejiang University
Medicinal chemistry updates of novel HDACs inhibitors (2020 to present).EBI
Hangzhou Normal University
Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification.EBI
Zhejiang University
Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).EBI
Hangzhou Normal University
Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities.EBI
Central South University
Discovery of Novel Tacrine-Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer's Disease.EBI
China Pharmaceutical University
Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities.EBI
Zhejiang University
Rational design, synthesis and biological evaluation of novel multitargeting anti-AD iron chelators with potent MAO-B inhibitory and antioxidant activity.EBI
Zhejiang University
Synthesis and biological evaluation of dihydrobenzofuran lignans and related compounds as potential antitumor agents that inhibit tubulin polymerization.EBI
University of Antwerp
Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer's disease.EBI
Zhejiang University
Discovery of small-molecule candidates against inflammatory bowel disease.EBI
Zhejiang University
Synthesis, in vitro and in vivo biological evaluation of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones as new potent anticancer agents.EBI
University of Bologna
Design, synthesis, and biological evaluation of 1,2,4-triazole bearing 5-substituted biphenyl-2-sulfonamide derivatives as potential antihypertensive candidates.EBI
China Pharmaceutical University
Identification of 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivatives as highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitors via metabolite profiling-based structural optimization.EBI
Shanghai Pharmaceuticals Holding